Recent evidence supports a role for heat-shock protein 70 (hsp70) and the 2
6 S proteasome in regulating apoptosis, although the precise nature of thei
r involvement is not known. In the present study, control and Bcl-x(L)-over
expressing, interleukin-3-dependent FL5.12 cell lines were treated with the
proteasome inhibitor N-benzoyloxycarbonyl (Z)-Leu-Leu-leucinal (MG132). Ba
sal proteasome activity appeared to be approximate to 30 % lower in bcl-x(L
) cells compared with control cells using a substrate for the chymotrypsin-
like activity. However, no difference in proteasome activity was detected u
sing substrates for the trypsin-like or peptidylglutamyl peptide-hydrolysin
g activities. In addition, protein levels of the 20 S proteasome beta-subun
it, as determined by Western blot analyses, were similar in control and bcl
-x(L) cells, leading to the conclusion that proteasome activities were the
same in these two cell lines. At 24 h after treatment with 500 nM MG132, ap
optosis in bcl-x(L) cells (22%) was less than that observed in control cell
s (34 %). Concomitantly, caspase activity in control cells, as assessed by
N-acetyl-L-aspartyl-L-glutamyl-L-valyl-L-aspartyl-7-amino-4-methylcoumarin
(Ac-DEVD-AMC), was twice that observed in bcl-x(L) cells. By 48 h after MG1
32 treatment, apoptosis and caspase activity in bcl-x(L) cells were similar
to those observed in control cells at 24 h, Proteasome inhibition stimulat
ed increases in hsp70 protein levels in control and bcl-x(L) cells by 12 h,
although the maximal increases found in bcl-x(L) cells were less. Blocking
this induction with hsp70 antisense oligonucleotides potentiated apoptosis
after treatment with MG132. Inhibiting caspase activity with a broad-spect
rum caspase inhibitor, t-butoxycarbonyl-Asp(OMe)-fluoromethyl ketone, preve
nted MG132-induced apoptosis. The more specific caspase-3 inhibitor, Ac-DEV
D-aldehyde, afforded less protection, although both inhibitors completely i
nhibited Ac-DEVD-AMC cleavage. These data indicate that both hsp70 and Bcl-
x(L) provide some protection against proteasome inhibitor-induced apoptosis
.